There has been a shakeup in markets since Donald Trump’s election, and investors have been positioning their portfolios to ...
After catching up with Pfizer’s Chairman and CEO, CFO, Chief Scientific Officer and Chief Strategy and Innovation Officer at the firm’s healthcare conference, JPMorgan analyst ...
CrowdStrike is back near highs despite crashing in July. Why Raymond James' David Cox calls it "immediately suspicious." ...
Aris stock surged to new highs this week, hitting its latest entry. The water solutions leader boasts an RS line at new highs ...